- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 13-07-2026: General Updates
13-07-2026 | 06:41 pm
13-07-2026 | 06:41 pm
Alembic Pharma reports a USFDA Warning Letter issued to a clinical investigator for work at its bioequivalence facility, citing an Informed Consent Form observation. No data integrity issues, operational restrictions, or material financial impact are anticipated.
No comments yet. Be the first to comment!